What Are Peptides? A Plain-Language Guide to the Science
A short chain of amino acids — but where any given peptide falls between approved medicine and unproven research chemical is the whole story.
If you have landed on a peptide product, a research summary, or a clinic page and found yourself wondering what the word actually means, this is the page to start with. The short answer is almost disappointingly simple: a peptide is a short chain of amino acids. The longer answer — what counts as “short,” which peptides your own body makes, which are FDA-approved medicines, which are sold “for research use only,” and why nearly all of them are injected rather than swallowed — is what separates an informed reader from a confused one. This page is the canonical starting point for everything else on Aminoscope.
What a peptide actually is
Amino acids are the small building-block molecules of biology; there are twenty common ones, and a cell strings them together in a specific order to build everything from enzymes to hormones. When two amino acids join, the bond between them is called a peptide bond, and a chain of amino acids linked this way is a peptide. That is the whole definition. The sequence of amino acids determines what the molecule does, the same way the order of letters determines a word. Insulin, oxytocin, and a research compound like BPC 157 are all just particular sequences of amino acids held together by peptide bonds.
The spectrum: amino acid → peptide → protein
Peptides and proteins are not different kinds of molecule; they are the same kind of molecule at different sizes. A single unit is an amino acid. A short chain is a peptide. A longer chain is a polypeptide, and a polypeptide that folds into a working three-dimensional shape is what we call a protein. The dividing line is a convention, not a law of nature: by common usage, chains of roughly two to fifty amino-acid residues are called peptides, and chains longer than about fifty are called proteins.[1] The cutoff is fuzzy on purpose — insulin, at 51 residues across two chains, sits right on the border and is described both ways. The practical point is that “peptide” just means “a fairly short amino-acid chain,” and nothing more mysterious than that.
Peptides your body already makes
Long before peptides became a wellness category, they were one of biology’s primary languages. Your body manufactures peptides as signaling molecules and hormones that tell distant tissues what to do. Insulin and glucagon regulate blood sugar; GLP-1 (glucagon-like peptide-1) is released from the gut after a meal to nudge insulin and curb appetite; oxytocin shapes bonding and labor; and growth-hormone-releasing hormone tells the pituitary to release growth hormone.[2] These are endogenous peptides — made internally, acting at exquisitely low concentrations, switched on and off with precision. Understanding that the body uses peptides as ordinary signals is the key to understanding why therapeutic peptides exist at all: many drugs in this class are simply copies of, or close cousins of, a signal the body already recognizes. The peptide sermorelin, for instance, mimics the growth-hormone-releasing hormone you already produce.
Therapeutic peptides: approved drugs versus “research” peptides
This is the distinction that matters most, and the one most often blurred in marketing. A large and growing share of modern medicines are peptides: more than eighty peptide drugs have been approved worldwide, with insulin (approved in the 1920s) the historic anchor and a steady wave of newer ones since.[3][5] Familiar examples include semaglutide, the GLP-1 medicine behind major weight-loss and diabetes outcomes (the trial record is here), and tesamorelin, an approved growth-hormone-releasing-hormone analog. These have been through controlled human trials, carry FDA labels, and are manufactured to pharmaceutical standards.
Set against that is a separate world of “research peptides” sold online and labeled “for research use only, not for human consumption.” Many of these — BPC 157 and TB-500 among the best known — have never completed a human trial, are not approved for any use, and are produced outside the controls that govern medicines. The label is a legal and regulatory line, not a quality guarantee, and it does not mean the compound has been shown to be safe or effective in people. Keeping the approved drug and the research peptide in separate mental boxes is the single most useful habit a reader can build.
Why most peptides are injected
A reasonable question is why, if peptides are made of the same amino acids as the protein in your food, you cannot just take them as a pill. The answer is that your digestive system is built to do exactly the opposite of what a peptide drug needs: it breaks proteins and peptides down into their constituent amino acids. Stomach acid and gut enzymes degrade most peptides before they can be absorbed, and the few fragments that survive struggle to cross the intestinal wall intact — so oral bioavailability is typically very poor.[4] That is why insulin, semaglutide in its injectable forms, and nearly every research peptide are given by injection, which bypasses the gut entirely. A handful of peptides have been engineered for oral use with absorption-enhancing formulations, but these are hard-won exceptions that prove the rule.[4] When you see a peptide sold as a powder to be reconstituted and injected, that delivery route is dictated by the chemistry, not by preference.
The evidence gradient
Perhaps the most important idea on this whole site is that “peptide” tells you nothing about how well something works. Evidence runs along a steep gradient. At one end sit FDA-approved peptide drugs backed by large randomized controlled trials in humans, with known dosing and known safety profiles. In the middle sit peptides with some human data but no approval. At the far end sit compounds whose entire case rests on cell-culture and rodent studies, with no human efficacy or safety evidence at all. Two molecules can both be “peptides” and sit at opposite ends of that gradient. Throughout Aminoscope we try to place each compound honestly on that scale rather than letting the category do the talking.
Where to go from here
With the vocabulary in place, the rest of the site becomes easier to navigate. If you want to see the full catalogue of individual compounds, browse our A–Z of molecules; if you want the broader picture of the field, the science, and how to read the claims responsibly, start with our peptide research hub. A peptide is a short chain of amino acids — but where any given peptide falls between “well-studied medicine” and “unproven research chemical” is the question worth carrying into every page that follows. This is general educational information, not medical advice.
Reviewed against primary sources by the Aminoscope desk
Sources
- [1] Forbes J, Krishnamurthy K. (2023). Biochemistry, Peptide. StatPearls (NCBI Bookshelf), National Library of Medicine. Source
- [2] National Institute of General Medical Sciences. (2024). Hormones and the endocrine system — peptide hormones as signaling molecules. National Institutes of Health (NIGMS). Source
- [3] Lau JL, Dunn MK. (2018). Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry. PMID 28720325
- [4] Drucker DJ. (2020). Advances in oral peptide therapeutics. Nature Reviews Drug Discovery. PMID 31848464
- [5] Muttenthaler M, King GF, Adams DJ, Alewood PF. (2021). Trends in peptide drug discovery. Nature Reviews Drug Discovery. PMID 33536635
Related tool
Peptide evidence matrix
See every peptide graded by how strong the human evidence actually is — filter by evidence tier, with a primary source on each grade.